These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36685546)

  • 81. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes.
    Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L
    Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytokine synthesis and apoptosis by intestinal intraepithelial lymphocytes: signaling of high density alpha beta T cell receptor+ and gamma delta T cell receptor+ T cells via T cell receptor-CD3 complex results in interferon-gamma and interleukin-5 production, while low density T cells undergo DNA fragmentation.
    Yamamoto M; Fujihashi K; Amano M; McGhee JR; Beagley KW; Kiyono H
    Eur J Immunol; 1994 Jun; 24(6):1301-6. PubMed ID: 8206090
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A fraction of CD3 epsilon subunits exists as disulfide-linked dimers in both human and murine T lymphocytes.
    Jin YJ; Koyasu S; Moingeon P; Steinbrich R; Tarr GE; Reinherz EL
    J Biol Chem; 1990 Sep; 265(26):15850-3. PubMed ID: 2144290
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Construction of a novel TROP2/CD3 bispecific antibody with potent antitumor activity and reduced induction of Th1 cytokines.
    Wang D; Zhang L; Wang B; Zhao L; Deng L; Xu W; Huang H
    Protein Expr Purif; 2023 May; 205():106242. PubMed ID: 36746324
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.
    Hayden MS; Linsley PS; Gayle MA; Bajorath J; Brady WA; Norris NA; Fell HP; Ledbetter JA; Gilliland LK
    Ther Immunol; 1994 Jan; 1(1):3-15. PubMed ID: 7584477
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Assembly and function of the T cell antigen receptor. Requirement of either the lysine or arginine residues in the transmembrane region of the alpha chain.
    Blumberg RS; Alarcon B; Sancho J; McDermott FV; Lopez P; Breitmeyer J; Terhorst C
    J Biol Chem; 1990 Aug; 265(23):14036-43. PubMed ID: 2143190
    [TBL] [Abstract][Full Text] [Related]  

  • 87. T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells.
    Janssen O; Wesselborg S; Heckl-Ostreicher B; Pechhold K; Bender A; Schondelmaier S; Moldenhauer G; Kabelitz D
    J Immunol; 1991 Jan; 146(1):35-9. PubMed ID: 1824593
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The implications of subunit interactions for the structure of the T cell receptor-CD3 complex.
    Koning F; Maloy WL; Coligan JE
    Eur J Immunol; 1990 Feb; 20(2):299-305. PubMed ID: 2138083
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy.
    Xie F; Zhang L; Shi S; Zheng A; Di J; Jin S; Miao X; Wu F; Chen X; Zhang Y; Wei X; Xu Y
    MAbs; 2022; 14(1):2115205. PubMed ID: 36041060
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells.
    Zhao Q; Pang J; Yan F; Jiang Y; Cui D; Liu J; Jing L; Li Y; Liu Z; Tao L; Zhao X; Diao A
    Protein Expr Purif; 2021 Feb; 178():105783. PubMed ID: 33122138
    [TBL] [Abstract][Full Text] [Related]  

  • 91. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta.
    Wang B; Wang N; Whitehurst CE; She J; Chen J; Terhorst C
    J Immunol; 1999 Jan; 162(1):88-94. PubMed ID: 9886373
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
    Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
    Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Selection for Anti-transferrin Receptor Bispecific T-cell Engager in Different Molecular Formats.
    Fu MP; Guo ZL; Tang HL; Zhu HF; Shen GX; He Y; Lei P
    Curr Med Sci; 2020 Feb; 40(1):28-34. PubMed ID: 32166662
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers.
    Wang N; Patel H; Schneider IC; Kai X; Varshney AK; Zhou L
    Antib Ther; 2021 Apr; 4(2):90-100. PubMed ID: 34169228
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma.
    Kim JH; Kim DS; Park HS; Kim YS
    Clin Immunol; 2023 Oct; 255():109755. PubMed ID: 37673224
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.
    Asano R; Ikoma K; Shimomura I; Taki S; Nakanishi T; Umetsu M; Kumagai I
    J Biol Chem; 2011 Jan; 286(3):1812-8. PubMed ID: 21097496
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy.
    Chen CY; Vander Kooi A; Cavedon A; Cai X; Hoggatt J; Martini PGV; Miao CH
    Mol Ther Nucleic Acids; 2023 Dec; 34():102043. PubMed ID: 37920545
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tuning the potency and selectivity of ImmTAC molecules by affinity modulation.
    Robertson IB; Mulvaney R; Dieckmann N; Vantellini A; Canestraro M; Amicarella F; O'Dwyer R; Cole DK; Harper S; Dushek O; Kirk P
    Clin Exp Immunol; 2024 Feb; 215(2):105-119. PubMed ID: 37930865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.